Your session is about to expire
← Back to Search
5mg SAD for Healthy Subjects
Study Summary
This trial is testing the safety, effectiveness, and how the body processes a new drug called BT-600 in healthy participants. The drug is designed to release a medication called tofacitinib in the
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are individuals older than 60 years of age eligible to participate in this study's recruitment process?
"Individuals seeking to participate in this research study must be between 19 and 50 years old as per the eligibility requirements."
Are there any ongoing efforts to enroll participants for this study?
"The current status on clinicaltrials.gov indicates that this investigation is actively pursuing potential participants. The trial was initially listed on 1/11/2024 and most recently revised on 2/16/2024."
Has the Food and Drug Administration authorized the use of 5 milligrams for Single Ascending Dose studies?
"According to our team at Power, the safety rating for 5mg SAD is rated as 1 on a scale from 1 to 3. This assessment aligns with it being in Phase I of the trial, indicating there is minimal data supporting its safety and effectiveness."
Do I meet the necessary criteria to participate in this experimental study?
"To qualify for participation in this research, individuals must be healthy and between 19 and 50 years old. The study is accepting approximately 48 participants."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger